A detailed history of Stonebrook Private Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Stonebrook Private Inc. holds 3,815 shares of ABT stock, worth $449,254. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,815
Previous 4,070 6.27%
Holding current value
$449,254
Previous $423 Million 2.84%
% of portfolio
0.12%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $25,517 - $30,123
-255 Reduced 6.27%
3,815 $435 Million
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $52,983 - $59,143
-526 Reduced 11.44%
4,070 $423 Million
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $17,194 - $18,990
157 Added 3.54%
4,596 $522 Million
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $400,353 - $490,065
4,439 New
4,439 $489 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stonebrook Private Inc. Portfolio

Follow Stonebrook Private Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebrook Private Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stonebrook Private Inc. with notifications on news.